C型肝炎ウイルス感染:グローバル治療薬の市場予測と分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 7
1.1 List of Tables15
1.2 List of Figures 21
2 Introduction 22
2.1 Catalyst 22
2.2 Related Reports 22
2.3 Upcoming Related Reports 23
3 Disease Overview 24
3.1 Etiology and Pathophysiology 24
3.1.1 Etiology 24
3.1.2 Pathophysiology 28
3.1.3 Prognosis 29
3.2 Symptoms 29
4 Epidemiology 31
4.1 Risk Factors and Comorbidities 31
4.1.1 The risk of contracting HCV is almost 50 times higher among injection drug users 32
4.1.2 There is a 10.9-fold increased risk of developing HCV infection through a blood transfusion 33
4.1.3 No current preventative therapy to reduce perinatal HCV transmission 33
4.1.4 Metabolic syndrome is a common comorbidity in HCV-infected individuals 34
4.1.5 Chronic alcoholism greatly magnifies the risk of HCC 35
4.1.6 HBV and HCV share similar modes of transmission, resulting in co-infection 35
4.1.7 HCV/HIV co-infection complicates treatment options and accelerates liver damage 35
4.2 Global Trends 36
4.2.1 US 37
4.2.2 5EU 38
4.2.3 Japan 41
4.2.4 Brazil 41
4.2.5 China 42
4.3 Forecast Methodology 43
4.3.1 Sources Used 43
4.3.2 Forecast Assumptions and Methods 47
4.3.3 Forecast Assumptions and Methods (HCV Genotypes) 51
4.3.4 Sources Not Used 55
4.4 Epidemiology Forecast for HCV (2012-2022) 55
4.4.1 Total Prevalent Cases of HCV 55
4.4.2 Age-Specific Prevalent Cases of HCV 58
4.4.3 Sex-Specific Prevalent Cases of HCV 61
4.4.4 Age-Standardized Prevalence of HCV 64
4.4.5 HCV Genotype Class Distributions 66
4.5 Discussion 67
4.5.1 Conclusion on Epidemiology Trends 67
4.5.2 Limitations of the Analysis 68
4.5.3 Strengths of the Analysis 69
5 Disease Management 70
5.1 Diagnosis and Referral Overview 70
5.2 Treatment Overview 71
5.3 US 74
5.3.1 Diagnosis 74
5.3.2 Clinical Practice 76
5.4 France 79
5.4.1 Diagnosis 79
5.4.2 Clinical Practice 80
5.5 Germany 81
5.5.1 Diagnosis 81
5.5.2 Clinical Practice 82
5.6 Italy 83
5.6.1 Diagnosis 83
5.6.2 Clinical Practice 83
5.7 Spain 84
5.7.1 Diagnosis 84
5.7.2 Clinical Practice 84
5.8 UK 86
5.8.1 Diagnosis 86
5.8.2 Clinical Practice 87
5.9 Japan 88
5.9.1 Diagnosis 88
5.9.2 Clinical Practice 88
5.10 Brazil 89
5.10.1 Diagnosis 89
5.10.2 Clinical Practice 90
5.11 China 90
5.11.1 Diagnosis 90
5.11.2 Clinical Practice 91
6 Competitive Assessment 92
6.1 Overview 92
6.2 Strategic Competitor Assessment 92
6.3 Product Profiles – Major Brands 94
6.3.1 Sovaldi and Sovaldi/Ledipasvir 94
6.3.2 Olysio 106
6.3.3 Incivek 114
6.3.4 Victrelis 121
6.3.5 Pegasys 127
6.3.6 PegIntron 133
6.3.7 Copegus, Rebetol, and Generic Ribavirin 139
6.3.8 Therapeutic Class: Interferon 144
7 Opportunity and Unmet Need 145
7.1 Overview 145
7.2 Unmet Needs 146
7.2.1 Unmet Need: Enhanced Efficacy in Difficult-to-Treat Patient Populations 146
7.2.2 Unmet Need: Improved Understanding of Drug-Drug Interactions 147
7.2.3 Unmet Need: Increased Disease Awareness and Diagnosis of HCV 148
7.2.4 Unmet Need: Reduced Cost of All-Oral Regimens 149
7.2.5 Unmet Need: Improved Treatment Tolerability 149
7.2.6 Unmet Need: Simplified Treatment Algorithm 150
7.2.7 Unmet Need: Shorter Treatment Duration 151
7.3 Unmet Needs Gap Analysis 152
7.4 Opportunities 153
7.4.1 Opportunity: Develop a Pan-Genotypic, All-Oral HCV Regimen 153
7.4.2 Opportunity: Target Difficult-to-Treat Patient Populations 153
7.4.3 Opportunity: Eliminate Ribavirin from All-Oral Regimens 154
7.4.4 Opportunity: Involvement of the Immune System 155
8 Pipeline Assessment 156
8.1 Overview 156
8.2 Clinical Trial Mapping 157
8.2.1 Clinical Trials by Country 157
8.3 Clinical Trials by Phase and Trial Status 158
8.4 Promising Direct-Acting Antivirals (DAAs) in Clinical Development 160
8.4.1 ABT-450/Ombitasvir + Dasabuvir 162
8.4.2 Faldaprevir 172
8.4.3 Daclatasvir, Daclatasvir + Asunaprevir, and Daclatasvir/Asunaprevir/BMS-791325 181
8.4.4 MK-5172/MK-8742 194
8.4.5 Vaniprevir 202
8.5 Other Drug Classes in Clinical Development 208
8.5.1 Interferon Derivatives 208
8.5.2 Host-Targeting Therapies 210
9 Current and Future Players 212
9.1 Overview 212
9.2 Trends in Corporate Strategy 214
9.3 Company Profiles 216
9.3.1 Merck 216
9.3.2 Roche 218
9.3.3 Vertex 221
9.3.4 Janssen 224
9.3.5 Gilead 226
9.3.6 AbbVie 231
9.3.7 Bristol-Myers Squibb 233
9.3.8 Boehringer Ingelheim 236
9.4 Additional Companies with Promising Drugs 239
9.4.1 Mitsubishi Tanabe Pharmaceutical Corporation 239
9.4.2 Achillion 240
9.4.3 Scynexis 241
9.4.4 Idenix 242
9.4.5 Presidio 243
9.4.6 Novartis 244
10 Market Outlook 246
10.1 Global Markets 246
10.1.1 Forecast 246
10.1.2 Drivers and Barriers – Global Issues 250
10.2 US 255
10.2.1 Forecast 255
10.2.2 Key Events 261
10.2.3 Drivers and Barriers 262
10.3 France 266
10.3.1 Forecast 266
10.3.2 Key Events 272
10.3.3 Drivers and Barriers 273
10.4 Germany 275
10.4.1 Forecast 275
10.4.2 Key Events 280
10.4.3 Drivers and Barriers 281
10.5 Italy 283
10.5.1 Forecast 283
10.5.2 Key Events 287
10.5.3 Drivers and Barriers 288
10.6 Spain 290
10.6.1 Forecast 290
10.6.2 Key Events 294
10.6.3 Drivers and Barriers 295
10.7 UK 297
10.7.1 Forecast 297
10.7.2 Key Events 302
10.7.3 Drivers and Barriers 303
10.8 Japan 305
10.8.1 Forecast 305
10.8.2 Key Events 311
10.8.3 Drivers and Barriers 312
10.9 Brazil 314
10.9.1 Forecast 314
10.9.2 Key Events 318
10.9.3 Drivers and Barriers 318
10.10 China 321
10.10.1 Forecast 321
10.10.2 Key Events 325
10.10.3 Drivers and Barriers 325
11 Appendix 328
11.1 Bibliography 328
11.2 Abbreviations 358
11.3 Methodology 361
11.4 Forecasting Methodology 361
11.4.1 Percent Drug-Treated Patients 361
11.4.2 Patient Warehousing 362
11.4.3 Drugs Included in Each Therapeutic Class 362
11.4.4 Launch and Patent Expiry Dates 363
11.4.5 General Pricing Assumptions 364
11.4.6 Individual Drug Assumptions 365
11.4.7 Generic Erosion 369
11.4.8 Selection of Pipeline Agents 369
11.4.9 Pricing of Pipeline Agents 370
11.5 Physicians and Specialists Included in This Study 374
11.6 Survey of Prescribing Physicians 376
11.7 About the Authors 377
11.7.1 Analysts 377
11.7.2 Epidemiologist 378
11.7.3 Therapy Area Director 378
11.7.4 Global Head of Healthcare 379
11.8 About GlobalData 380
11.9 Disclaimer 380


【レポート販売概要】

■ タイトル:C型肝炎ウイルス感染:グローバル治療薬の市場予測と分析
■ 英文:PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update
■ 発行日:2014年5月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC001EPIDR
■ 調査対象地域:グローバル
  • 時計の世界市場2017-2021
    About WatchThe global watch market is categorized into quartz and mechanical. Mechanical watches can be further classified into automatic and hand wound, while quartz watches are classified into analog and digital. It has huge market potential due to increasing technological design innovations. Moreover, the current positioning of this product enables users to make a style statement. Technavio’s a …
  • Cairn India Limited:石油・ガスの開発・生産動向及びコスト分析– 2012
    Cairn India Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Cairn India Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
  • マカフィーのIoT戦略、開発動向
    The world is moving beyond standalone devices into a new era in which everything is connected. The Internet of Things (IoT) refers to uniquely identifiable objects (things) and their virtual representations in an Internet-like structure. Stated differently, the concept involves the notion that there are many things (assets, objects, etc.) in the world that may be addressed/labeled/cataloged for va …
  • 北米の心臓血管外科用機器市場見通し(~2021)
    North America Cardiovascular Surgery Outlook to 2021 Summary GlobalData’s new report, "North America Cardiovascular Surgery Outlook to 2021", provides key procedures data on the North America Cardiovascular Surgery. The report provides procedure volumes within market segments - Coronary Artery Bypass Graft (CABG) Procedures and Isolated Valve Procedures. The data in the report is derived from dyna …
  • ストレージ管理の世界市場:ハードウェア、ソフトウェア、サービス
    About global storage management Over the years, business enterprises worldwide have become increasingly dependent on technology. We expect this trend to intensify. Storage management is the process of enhancing the efficiency of electronic data storage. It monitors and tracks the performance of storage areas, which enables optimization and proactive management of storage devices. In addition, it m …
  • 集光型太陽光発電(CPV)のグローバル市場(2014-2018)
    About Solar Concentrated Photovoltaics A solar CPV system concentrates sunlight on solar cells with the help of an optical device, increasing the efficiency of photovoltaic cells that convert energy from sunlight directly into electricity. The optics used concentrates the sunlight by a factor of 500 to 1,000 and focuses it on the solar cells, which are reduced to a small fraction of the CPV module …
  • スマートグリッドデータ管理の世界市場2016-2020
    About Smart Grid Data Management A smart grid generates a lot of data on a daily basis at different points such as smart meters installed in homes, at utilities' end, etc. These massive amounts of generated data are collected, stored, transmitted and analysed to predict electricity demand patterns and consequently, manage the production. The smart grid data management takes into account the entire …
  • スマートプラグの世界市場2017-2021
    About Smart Plug Smart plugs transform ordinary appliances into smart appliances. They are cost-effective alternatives for smart appliances. The technology is expected to have a high penetration among millennials. The use of and dependence on devices that can be controlled remotely through a wireless connection is increasing globally, which is a key factor that is driving the smart plug market. Th …
  • Kodiak Oil & Gas Corp.社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Kodiak Oil & Gas Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Kodiak Oil & Gas Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
  • 世界のHadoop市場動向(2012-2016)
    TechNavio's analysts forecast the Global Hadoop market to grow at a CAGR of 55.63 percent over the period 2012-2016. One of the key factors contributing to this market growth is the demand for big data analytics. The Global Hadoop market has also been witnessing the emergence of hadoop-as-a-service (HDaaS) solutions. However, the lack of trained professionals could pose a challenge to the growth o …
  • スピーカーの世界市場2016-2020:ホームオーディオ用スピーカー、ポータブルスピーカー
    A speaker is an audio system that converts electromagnetic waves into sound waves. Speakers can be categorized based on the technology they use. Based on technology, we have categorized speakers as wired and wireless speakers. Wireless is the latest technology used in speakers. Bluetooth and soundbar audio systems are equipped with wireless technology. Home theater systems are one of the most popu …
  • 世界の軍用回転翼航空機の市場動向2013-2023:競合環境及び戦略的インサイト
    The report provides a detailed analysis of the competitive landscape of the Military Rotorcraft market. It provides an overview of key Military Rotorcraft companies catering to the Military Rotorcraft sector, together with insights such as key alliances, strategic initiatives and a brief financial analysis. The global rotorcraft industry is highly concentrated with the majority of the market captu …
  • Market Opportunity: Call Continuity in Voice over LTE (VoLTE)
    Fourth generation (4G) data services are in the deployment stage, but is will be a few years until there is ubiquitous LTE coverage. Meanwhile, there are competitive threats emerging against incumbent carriers’ core voice services. This is coming at a time when all bearer services (voice and data) are becoming marginalized due to market expectations, economic conditions, and a coming supply side e …
  • ゴールドローン市場動向(2012-2016):インド
    TechNavio's analysts forecast the Gold Loan market in India to grow at a CAGR of 26.33 percent over the period 2012-2016. One of the key factors contributing to this market growth is gold loan business’ high return on investment. The Gold Loan Market in India has also been witnessing frequent gold price fluctuations. However, RBI’s capping on loan-to-value ratio for non-banking financial companies …
  • 特殊任務航空機の世界市場予測(~2020)
    The global special mission aircraft market is projected to grow from USD 10.49 Billion in 2015 to USD 12.49 Billion by 2020, at a CAGR of 3.5% from 2015 to 2020. Economic development and geopolitical instability in varied regions has resulted in increasing the defense spending in order to modernize defense mechanisms to protect borders from external as well as internal threats. This is expected to …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。